LexaGene Talking to Major Players in Plague Detection

by | Nov 18, 2021 | Biothreat Detection

Home » Biothreat Detection » LexaGene Talking to Major Players in Plague Detection

CEO Dr. Jack Regan joined Steve Darling from Proactive Investors to share news the company will be approaching Government and showing the effectiveness and speed of their MiQLab ™ in detecting plague.

BioThreat Detection

LexaGene’s MiQLab System drastically shortens the time gap between  pathogen identification enabling an organization to maximize containment efforts and minimize the impact on food, water, and people.

Point of Need Diagnostics for Effective Pathogen Monitoring

Rapid Biothreat Detection within hours instead of days enabling improved preparedness improving food, water, and human safety.

Customizable:  Detect up to 27 Targets of Interest from a single sample using a fully integrated sample-to-answer system that provides easy to interpret results.

Easy to Use Open-Access Feature enables assay deployment within weeks and hands on time of less than one minute as compared to closed-access systems.

<a href="https://lexagene.com/author/lexagene-admin/" target="_self">LexaGene</a>

LexaGene

LexaGene develops fully automated, rapid molecular testing at the point-of-need for accurate pathogen detection in human clinical diagnostics, veterinary diagnostics, food safety, and other markets.

Survey Says Veterinarians Have an Appetite for In-Clinic Diagnostic Technology

This spring LexaGene conducted a market research survey in conjunction with AAHA to assess the opinions of practicing veterinarians on AMR stewardship and the use of antibiotics in the treatment of companion animals.

The Dawn of the Superbugs

The most menacing of all resistant bacteria are the so called “super bugs”- strains of bacteria that are resistant to several different classes of antibiotics or multidrug resistant.

LexaGene offers North Shore Technology Council (NSTC) and Leadership Team at MassBio a tour of our Beverly Facility

Recently, we welcomed members of North Shore Technology Council and MassBio Leadership Teams into our facility at 500 Cummings Center for a full tour of our office space and laboratory spaces.

Upcoming Events

No events in this category to show at this time.

Latest Resources


LexaGene’s MiQLab™ System, a TRL-7 technology, drastically shortens the time gap between novel pathogen identification and point-of-need testing through its open-access feature.